In vitro cytotoxicity against fresh human tumors and P388 leukemia predicts the differential in vivo activity of a series of anthracene anticancer drugs.

Source:http://linkedlifedata.com/resource/pubmed/id/1958855

Download in:

View as

General Info

PMID
1958855